Cancer treatment company plans for public offeringJuly 25, 2019PetCure Oncology has engaged Boustead Securities for a Regulation D 506(c) offering.
SPONSORED CONTENTUncompromising renal + sensitivities care.Managing pain from canine OA doesn’t have to be complicated. Discover an approach that doesn’t just treat pain, but addresses inflammation, too. + Learn More